NCT02128932 · Interventional trial
Efficacy and Safety of Semaglutide Once Weekly Versus Insulin Glargine Once Daily as add-on to Metformin With or Without Sulphonylurea in Insulin-naïve Subjects With Type 2 Diabetes
Overall registry status Completed
Phase 3
Conditions Diabetes, Diabetes Mellitus, Type 2
Delaware Valley sites
- Novo Nordisk Investigational Site · Berlin, NJ · Camden County
- Novo Nordisk Investigational Site · Lansdale, PA · Montgomery County
- Novo Nordisk Investigational Site · Philadelphia, PA · Philadelphia County
- Novo Nordisk Investigational Site · Trenton, NJ · Mercer County
First posted
Registry updated
Added to the directory